Article Text

Download PDFPDF
Weighty matters
  1. Geoffrey K Herkes
  1. Correspondence to Professor Geoffrey K Herkes, Department of Neurology, Royal North Shore Hospital, 66 Pacific Hwy, St Leonards, NSW 2065, Australia; gherkes{at}nsccahs.health.nsw.gov.au

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Weighty matters

Antiepileptic drug therapy for epilepsy and mood disorders and pain management has been greatly enhanced and expanded by a growing array of therapeutic options. With choice comes the need for knowledge about the potential adverse effects of medications that may be taken lifelong. The adverse event profile of the established antiepileptic drug therapies is well established, but that of the newer agents continues to grow. Much of the known side effect profile comes from clinical trial data, which do not reflect the pattern or nature of use once an agent is marketed and available to the wider community.

Weight …

View Full Text

Footnotes

  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • Epilepsy
    William Owen Pickrell Arron S Lacey Rhys H Thomas Philip E M Smith Mark I Rees